Trial Profile
The Clinical Application of Tumor Reversion: A Phase I Study of Sertraline (Zoloft) in Combination With Timed-sequential Cytosine Arabinoside (Ara-C) in Adults With Relapsed and Refractory Acute Myeloid Leukemia (AML)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Apr 2023
Price :
$35
*
At a glance
- Drugs Sertraline (Primary) ; Cytarabine
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 10 Apr 2023 Status changed from recruiting to completed.
- 26 Sep 2018 Planned End Date changed from 31 Dec 2018 to 1 Dec 2020.
- 26 Sep 2018 Planned primary completion date changed from 31 Jul 2018 to 1 Jul 2020.